Calidi Biotherapeutics, Inc. (CLDI)
Data as of , from SEC Form 4 filings.
See up to 3 months of CLDI. The 7-day demo opens the 1M and 3M ranges and puts CLDI on your watchlist.
Start 7-day demoLatest CLDI insider trades
About Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. files with the SEC under CIK 0001855485 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
CLDI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 85,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CLDI insider transactions (Form 4)
2925 Form 4 filings on record, the earliest from Oct 15, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| George Peoples - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 4,000 | $0.00 | - | |
| Scott Leftwich - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 4,000 | $0.00 | - | |
| Alan R. Stewart - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 4,000 | $0.00 | - | |
| Andrew C. Jackson - Officer | Grant or award | Stock Options (right to buy) | 14,000 | - footnote F1 | - | |
| ||||||
| James A. Schoeneck - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 5,000 | $0.00 | - | |
| Eric E. Poma - Officer | Grant or award | Stock Options (right to buy) | 32,000 | - footnote F1 | - | |
| ||||||
| Santidrian Antonio Fernandez - Officer | Grant or award | Stock Options (right to buy) | 16,000 | - footnote F1 | - | |
| ||||||
| Corazon (Corsee) D. Sanders - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 6,000 | $0.00 | - | |
| Allan Camaisa - Director | Open-market sale | Common Stock | 850 footnote F1 | $1.46 | $1K | |
| ||||||
| Santidrian Antonio Fernandez - Officer | Grant or award | Stock Options (right to buy) | 35,000 | - | - | |
| Andrew C. Jackson - Officer | Grant or award | Stock Options (right to buy) | 30,000 | - | - | |
| Eric E. Poma - Officer | Grant or award | Stock Options (right to buy) | 10,000 | - | - | |
| James A. Schoeneck - Director | Open-market purchase | Common Stock | 75,000 | $2.00 | $150K | |
| James A. Schoeneck - Director | Open-market purchase | Warrant (right to buy) | 75,000 | - | - | |
| Eric E. Poma - Officer | Open-market purchase | Common Stock | 25,000 | $2.00 | $50K | |
| Eric E. Poma - Officer | Open-market purchase | Warrant (right to buy) | 25,000 | - | - | |
| Scott Leftwich - Director | Open-market purchase | Common Stock | 125,000 | $2.00 | $250K | |
| Scott Leftwich - Director | Open-market purchase | Warrant (right to buy) | 125,000 | - | - | |
| Andrew C. Jackson - Officer | Open-market purchase | Common Stock | 2,500 | $2.00 | $5K | |
| Andrew C. Jackson - Officer | Open-market purchase | Warrant (right to buy) | 2,500 | - | - | |
| George Peoples - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 137,078 | $0.00 | - | |
| Scott Leftwich - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 137,078 | $0.00 | - | |
| Alan R. Stewart - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 137,078 | $0.00 | - | |
| James A. Schoeneck - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 164,493 | $0.00 | - | |
| Allan Camaisa - Officer | Open-market sale | Common Stock | 10,000 | $1.62 | $16K | |
| Scott Leftwich - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 20,217 | - | - | |
| George Peoples - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 20,217 | - | - | |
| Alan R. Stewart - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 20,217 | - | - | |
| James A. Schoeneck - Director | Grant or award | Non-Qualified Stock Options (right to buy) | 20,217 | - | - | |
CLDI insider trading FAQ
What is the latest insider trade for CLDI?
Calidi Biotherapeutics, Inc. (CLDI) had 8 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for CLDI runs to 25 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CLDI stock?
No insider purchases of CLDI were filed in the last 90 days. 8 purchases are on record for this company.
How many insiders are selling CLDI stock?
No insider sales of CLDI were filed in the last 90 days. 2 sales are on record for this company.
Where can I see CLDI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CLDI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - George Peoples view on EDGAR
- - Scott Leftwich view on EDGAR
- - Alan R. Stewart view on EDGAR
- - Andrew C. Jackson view on EDGAR
- - James A. Schoeneck view on EDGAR
- - Eric E. Poma view on EDGAR
- - Santidrian Antonio Fernandez view on EDGAR
- - Corazon (Corsee) D. Sanders view on EDGAR
- - Allan Camaisa view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CLDI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CLDI with a 7-day demo
- CLDI on your watchlist
- Every CLDI Form 4 filing on record
- Up to 3 months of CLDI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
